Detalhe da pesquisa
1.
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents.
Support Care Cancer
; 32(1): 47, 2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127246
2.
Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives.
Support Care Cancer
; 28(10): 4589-4612, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32533435
3.
A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC).
Ann Oncol
; 29(2): 452-458, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29092012
4.
Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane.
Ann Oncol
; 29(5): 1195-1202, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29447329
5.
European Society for Medical Oncology (ESMO) position paper on supportive and palliative care.
Ann Oncol
; 29(1): 36-43, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29253069
6.
Clinical equivalence with G-CSF biosimilars: methodologic approach in a (neo)adjuvant setting in non-metastatic breast cancer.
Support Care Cancer
; 26(1): 33-40, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28929372
7.
Integrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitant.
Ann Oncol
; 28(6): 1268-1273, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28327932
8.
The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting.
Ann Oncol
; 28(6): 1260-1267, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28398530
9.
Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study).
Ann Oncol
; 27(11): 2039-2045, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27793849
10.
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.
Ann Oncol
; 27(11): 2046-2052, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502725
11.
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
Ann Oncol
; 27(3): 379-90, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26681681
12.
Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review.
Ann Oncol
; 26(6): 1081-1090, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25755107
13.
Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary.
Ann Oncol
; 26(6): 1058-1068, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25635006
14.
Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis.
Ann Oncol
; 26(4): 688-695, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25542926
15.
Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN).
Ann Oncol
; 26(8): 1677-84, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25735315
16.
Bone health in cancer: ESMO Clinical Practice Guidelines.
Ann Oncol
; 31(12): 1650-1663, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801018
17.
Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013.
Ann Oncol
; 26(3): 463-76, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25015334
18.
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5).
Ann Oncol
; 31(12): 1623-1649, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32979513
19.
Bone health in cancer patients: ESMO Clinical Practice Guidelines.
Ann Oncol
; 25 Suppl 3: iii124-37, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24782453
20.
Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force.
Ann Oncol
; 25(8): 1492-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24569913